0.00Open0.05Pre Close0 Volume110 Open Interest21.50Strike Price0.00Turnover5714.09%IV7.97%PremiumNov 1, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0732Delta0.0879Gamma399.20Leverage Ratio-137.0461Theta0.0000Rho29.24Eff Leverage0.0000Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet